Roche introduces new Accu-Chek Mobile glucose monitoring device

Roche Diagnostics Canada, a trailblazer in the healthcare field, is proud to introduce Accu-Chek® Mobile, the first strip-free blood glucose monitoring device available on the market. The state-of-the-art Accu-Chek® Mobile system eliminates the need to handle used lancets and test strips. Specially developed for people living with diabetes, the device yields accurate, reliable blood glucose readings within five seconds, making it a particularly practical solution for users of rapid-acting insulin.

For the 3 million Canadians with diabetes, and especially the 10% who have type 1 diabetes, the new Accu-Chek® Mobile glucose monitoring device provides, at long last, a quick, simple way of checking blood glucose levels. '' For people who live with diabetes, there are many daily steps involved in managing their disease, says Lori Berard, RN CDE Nurse Manager at the University of Manitoba's Diabetes Research Center. For someone who has not had diabetes touch their lives, it may appear as though a blood glucose checking is a rather simplistic task, but it is rather complex. Lightweight and portable, the device features a unique test cassette pre-loaded with a continuous testing tape and a lancet drum. It also boasts a simplified three-step testing process, compared with the average 11 steps required with single strip devices. Accu-Chek® Mobile allows users to perform up to 50 tests before replacing the cassette. The fast, convenient device provides readings within five seconds, with only a minimal blood sample, thanks to the improved Accu-Chek FastClix lancet system.  "This type of system will make monitoring blood glucose easier, and much more efficient," states Berard.

Accu-Chek® Mobile can also store up to 500 readings as well as averages over 7, 14 and 30 days, enabling users to consult their testing history and thus allow them to better manage their blood glucose levels over time. Moreover, data from the device can be uploaded to Excel or Accu-Chek® software for tracking purposes.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roche Sequencing and Life Science. (2019, June 19). Roche introduces new Accu-Chek Mobile glucose monitoring device. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20110428/Roche-introduces-new-Accu-Chek-Mobile-glucose-monitoring-device.aspx.

  • MLA

    Roche Sequencing and Life Science. "Roche introduces new Accu-Chek Mobile glucose monitoring device". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20110428/Roche-introduces-new-Accu-Chek-Mobile-glucose-monitoring-device.aspx>.

  • Chicago

    Roche Sequencing and Life Science. "Roche introduces new Accu-Chek Mobile glucose monitoring device". News-Medical. https://www.news-medical.net/news/20110428/Roche-introduces-new-Accu-Chek-Mobile-glucose-monitoring-device.aspx. (accessed December 22, 2024).

  • Harvard

    Roche Sequencing and Life Science. 2019. Roche introduces new Accu-Chek Mobile glucose monitoring device. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20110428/Roche-introduces-new-Accu-Chek-Mobile-glucose-monitoring-device.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Roche receives Breakthrough Device Designation from FDA for new Alzheimer's disease assays